EGLN1 and Hepatic fibrosis: In earlier studies, HIF-1α was associated with TGFβ activation in hepatocytes and human umbilical vein endothelial cells during hepatic fibrosis, and TGFβ also inhibited mRNA and protein expression of PHD2, thereby increasing the stability of HIF-1α (41, 42).